-
1 Comment
Agilent Technologies, Inc is currently in a long term uptrend where the price is trading 21.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.2.
Agilent Technologies, Inc's total revenue rose by 14.1% to $2B since the same quarter in the previous year.
Its net income has increased by 46.2% to $288M since the same quarter in the previous year.
Finally, its free cash flow grew by 311.8% to $197M since the same quarter in the previous year.
Based on the above factors, Agilent Technologies, Inc gets an overall score of 5/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | US00846U1016 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Target Price | None |
---|---|
Dividend Yield | 1.0% |
Market Cap | 26B |
PE Ratio | 23.82 |
Beta | 1.19 |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for AG8.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025